BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15538726)

  • 21. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
    Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
    J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell antigen-1+ cell-based bone morphogenetic protein-4 gene transfer strategy in mice failed to promote endosteal bone formation.
    Hall SL; Chen ST; Gysin R; Gridley DS; Mohan S; Lau KH
    J Gene Med; 2009 Oct; 11(10):877-88. PubMed ID: 19629966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishment of immortalized multipotent hematopoietic progenitor cell lines by retroviral-mediated gene transfer of beta-catenin.
    Templin C; Kotlarz D; Rathinam C; Rudolph C; Schätzlein S; Ramireddy K; Rudolph KL; Schlegelberger B; Klein C; Drexler H
    Exp Hematol; 2008 Feb; 36(2):204-15. PubMed ID: 18206728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo methotrexate selection of murine hemopoietic cells transduced with a retroviral vector for Gaucher disease.
    Havenga M; Valerio D; Hoogerbrugge P; Es H
    Gene Ther; 1999 Oct; 6(10):1661-9. PubMed ID: 10516714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors.
    Tian C; Bagley J; Forman D; Iacomini J
    Gene Ther; 2006 Apr; 13(7):652-8. PubMed ID: 16341058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate selection of long-term culture initiating cells following transduction of CD34(+) cells with a retrovirus containing a mutated human dihydrofolate reductase gene.
    Takebe N; Xu LC; MacKenzie KL; Bertino JR; Moore MA
    Cancer Gene Ther; 2002 Mar; 9(3):308-20. PubMed ID: 11896448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model.
    Heim DA; Hanazono Y; Giri N; Wu T; Childs R; Sellers SE; Muul L; Agricola BA; Metzger ME; Donahue RE; Tisdale JF; Dunbar CE
    Mol Ther; 2000 Jun; 1(6):533-44. PubMed ID: 10933978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo expansion of transduced murine hematopoietic cells with a selective amplifier gene.
    Kume A; Koremoto M; Xu R; Okada T; Mizukami H; Hanazono Y; Hasegawa M; Ozawa K
    J Gene Med; 2003 Mar; 5(3):175-81. PubMed ID: 12666183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retroviral transduction of murine hematopoietic stem cells.
    Haviernik P; Zhang Y; Bunting KD
    Methods Mol Biol; 2008; 430():229-41. PubMed ID: 18370303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates.
    Takatoku M; Sellers S; Agricola BA; Metzger ME; Kato I; Donahue RE; Dunbar CE
    J Clin Invest; 2001 Aug; 108(3):447-55. PubMed ID: 11489938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new red fluorescent protein that allows efficient marking of murine hematopoietic stem cells.
    Sanuki S; Hamanaka S; Kaneko S; Otsu M; Karasawa S; Miyawaki A; Nakauchi H; Nagasawa T; Onodera M
    J Gene Med; 2008 Sep; 10(9):965-71. PubMed ID: 18613301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The presence of the carboxy-terminal fragment of fibronectin allows maintenance of non-human primate long-term hematopoietic repopulating cells during extended ex vivo culture and transduction.
    Sellers SE; Tisdale JF; Agricola BA; Donahue RE; Dunbar CE
    Exp Hematol; 2004 Feb; 32(2):163-70. PubMed ID: 15102477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells.
    Yoshimitsu M; Higuchi K; Ramsubir S; Nonaka T; Rasaiah VI; Siatskas C; Liang SB; Murray GJ; Brady RO; Medin JA
    Gene Ther; 2007 Feb; 14(3):256-65. PubMed ID: 16929352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preselective gene therapy for Fabry disease.
    Qin G; Takenaka T; Telsch K; Kelley L; Howard T; Levade T; Deans R; Howard BH; Malech HL; Brady RO; Medin JA
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3428-33. PubMed ID: 11248095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Green fluorescent protein as a selectable marker of retrovirally transduced hematopoietic progenitors.
    Kume A; Hashiyama M; Suda T; Ozawa K
    Stem Cells; 1999; 17(4):226-32. PubMed ID: 10437986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful therapeutic effect in a mouse model of erythropoietic protoporphyria by partial genetic correction and fluorescence-based selection of hematopoietic cells.
    Fontanellas A; Mendez M; Mazurier F; Cario-André M; Navarro S; Ged C; Taine L; Géronimi F; Richard E; Moreau-Gaudry F; Enriquez De Salamanca R; de Verneuil H
    Gene Ther; 2001 Apr; 8(8):618-26. PubMed ID: 11320408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice.
    Ema H; Sudo K; Seita J; Matsubara A; Morita Y; Osawa M; Takatsu K; Takaki S; Nakauchi H
    Dev Cell; 2005 Jun; 8(6):907-14. PubMed ID: 15935779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
    Lamers CH; van Elzakker P; Langeveld SC; Sleijfer S; Gratama JW
    Cytotherapy; 2006; 8(6):542-53. PubMed ID: 17148030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice.
    Chan J; Clements W; Field J; Nasa Z; Lock P; Yap F; Toh BH; Alderuccio F
    J Gene Med; 2006 Nov; 8(11):1281-90. PubMed ID: 16989008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.